Ledger.Open graph →
SEC Form D · filed August 31, 2023

Inhibrx, Inc

Offering
$200.0M
Sold
$200.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
LA JOLLA, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Brendan Eckelman · La Jolla, CAExecMark Lappe · La Jolla, CAExec · DirectorJon F. Kayyem · La Jolla, CADirectorKelly F. Deck · La Jolla, CAExecTimothy Mahlman · Bellevue, WAExecIan Sigalow · Bellevue, WADirectorRyan Craig · New York, NYExec · DirectorKaran Choudhary · Pembroke Pines, FLExecKristiina Vuori · Newtown, PADirectorKimberly Manhard · La Jolla, CADirectorDouglas Forsyth · San Diego, CADirectorSterling Sponsor RFI II, LLC · Uniondale, NYDirectorBethany V. Chang · Los Angeles, CAExecEly C. Greenberg · PORTLAND, ORExec · DirectorSteven L. Bock · NATICK, MAExecKristiina Vuori · Newtown, PADirectorKimberly Manhard · La Jolla, CADirectorDouglas Forsyth · La Jolla, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗